MedTrace Logo

Clinical Application of CTC in Operable Breast Cancer Patients

NCT03842176 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2019-04-03

No results posted yet for this study

Summary

The investigators aim to evaluate the possibility of clinical application of CTC detection in samples or peripheral blood of breast cancer patients, so as to act as the new techniques or indicators of early diagnosis, therapy efficiency, or postoperative surveillance of breast cancer.

Conditions

Interventions

PROCEDURE

Neoadjuvant chemotherapy before surgery

The operable breast cancer patients takes neoadjuvant chemotherapy before surgery.

PROCEDURE

Surgery followed by adjuvant chemotherapy

The operable breast cancer patients takes surgery followed by adjuvant chemotherapy.

Sponsors & Collaborators

  • Peking Union Medical College Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2019-07-31
Completion
2019-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03842176 on ClinicalTrials.gov